The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The relationship between time since registration and measured incidence rates in the General Practice Research Database
Abstract
BACKGROUND: The General Practice Research Database (GPRD) is widely used to study incidence rates. This study examines whether incidence rates are overestimated during the first year after registration, how long one needs to wait to obtain accurate incidence rates, and whether the time period of overestimation differs among disease types. METHODS: We measured incidence rates of nine acute, eight chronic, and eight neoplastic outcomes in 3-month intervals through month 36 after enrollment in GPRD. The incidence rates in months 13-36 were used to estimate baseline incidence rates for each diagnosis. RESULTS: For patients registering with practices that were already UTS, incidence rates were highest in the first 3 months after registration. In eight of nine acute diagnoses, the incidence rate was within 20% of baseline by months 4-6; and in seven of eight cancers, the incidence rate was within 20% of baseline by months 7-9. For chronic conditions, the incidence rate in months 10-12 differed from baseline by more than 20% for five of the eight outcomes, respectively. For patients registering prior to UTS, incidence rates during the first quarter were within 20% of baseline for all acute and cancer diagnoses and six of eight chronic diagnoses. CONCLUSIONS: Reported incidence rates are highest in the first 3 months after registration with an UTS practice and decline to baseline over the first year, more quickly for acute conditions than chronic conditions. For patients who registered prior to UTS, incidence rates are near the baseline level at the start of follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of fractures in England and Wales
van Staa, T. P., Dennison, E. M., Leufkens, H. G. M., & Cooper, C. (2001) · Bone · doi:10.1016/s8756-3282(01)00614-7 · Cited by 1,133
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study
HUBBARD, R., VENN, A., LEWIS, S., & BRITTON, J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9906062 · Cited by 639
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Koro, C. E., Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L., Kreyenbuhl, J., Revicki, D., & Buchanan, R. (2002) · BMJ · doi:10.1136/bmj.325.7358.243 · Cited by 421
Langman, M. J. S. (2000) · BMJ · doi:10.1136/bmj.320.7250.1642 · Cited by 419
Incidence and Natural History of Paget's Disease of Bone in England and Wales
Van Staa, T. P., Selby, P., Leufkens, H. G. M., Lyles, K., Sprafka, J. M., & Prof. Cooper, C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.465 · Cited by 369
García Rodríguez, L. A., & Huerta-Alvarez, C. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00015 · Cited by 359
Inflammatory bowel disease is not associated with an increased risk of lymphoma
Lewis, J. D., Bilker, W. B., Brensinger, C., Deren, J. J., Vaughn, D. J., & Strom, B. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.28703 · Cited by 296
Self-citationWatson, D. J., Rhodes, T., & Guess, H. A. (2003) · PubMed · Cited by 284
Jick, H., Terris, B. Z., Derby, L. E., & Jick, S. S. (1992) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630010607 · Cited by 265
Inflammatory Bowel Disease Is Not Associated With An Increased Risk Of Lymphoma
&NA; (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200112000-00025 · Cited by 250
Watson, D. J., Rhodes, T., Cai, B., & Guess, H. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1105 · Cited by 238
Opstelten, W. (2002) · Family Practice · doi:10.1093/fampra/19.5.471 · Cited by 228
Antibiotics and Risk of Subsequent First-time Acute Myocardial Infarction
Meier, C. R. (1999) · JAMA · doi:10.1001/jama.281.5.427 · Cited by 195
Lewis, J. D., Brensinger, C., Bilker, W. B., & Strom, B. L. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.698 · Cited by 189
Self-citationValidation of the diagnosis of venous thromboembolism in general practice database studies
Lawrenson, R., Todd, J. ‐., Leydon, G. M., Williams, T. J., & Farmer, R. D. T. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00199.x · Cited by 180
Hansell, A., Hollowell, J., Nichols, T., McNiece, R., & Strachan, D. (1999) · Thorax · doi:10.1136/thx.54.5.413 · Cited by 171
The VAMP research multi-purpose database in the U.K.
Lis, Y. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00137-f · Cited by 116
Association between migraine and asthma: matched case-control study.
Davey, G., Sedgwick, P. M., Maier, W., Visick, G., Strachan, D. P., & Anderson, H. R. (2002) · Europe PMC (PubMed Central) · Cited by 114
Respiratory medications and risk of asthma death
Lanes, S. (2002) · Thorax · doi:10.1136/thorax.57.8.683 · Cited by 108
Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database
Soriano, J. B., Maier, W. C., Visick, G., & Pride, N. B. (2001) · European Journal of Epidemiology · doi:10.1023/a:1021235123382 · Cited by 98
Kornegay, C. J., Vasilakis‐Scaramozza, C., & Jick, H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0902 · Cited by 98
Statins and the risk of idiopathic venous thromboembolism
Yang, C., Jick, S. S., & Jick, H. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01523.x · Cited by 74
One‐year follow‐up of newly diagnosed irritable bowel syndrome patients
Ruigómez, A., Wallander, Johansson, & Rodriguez, L. A. G. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00576.x · Cited by 71
Seaman, H. E. (2003) · Human Reproduction · doi:10.1093/humrep/deg120 · Cited by 61
Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome?
Ruigómez, A., Rodríguez, L. A. G., Johansson, S., & Wallander, M.-A. A. (2003) · Maturitas · doi:10.1016/s0378-5122(02)00321-3 · Cited by 60
Increasing prevalence of asthma in UK primary care during the 1990s.
Soriano, J. B., Kiri, V. A., Maier, W. C., & Strachan, D. P. (2003) · PubMed · Cited by 59
Risk of irritable bowel syndrome among asthma patients
Huerta, C., Rodríguez, L. A. G., Wallander, M.-A. A., & Johansson, S. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.666 · Cited by 53
Hardy, J. R., Holford, T. R., Hall, G. C., & Bracken, M. B. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.935 · Cited by 51
The UK General Practice Research Database
Rodríguez, L. A. G., Perez‐Gutthann, S., & Jick, S. S. (2000) · Pharmacoepidemiology · doi:10.1002/0470842555.ch23 · Cited by 46
Kaye, J. A., Derby, L. E., Melero-Montes, M. D. M., Quinn, M., & Jick, H. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1493 · Cited by 45
Breast cancer incidence and use of antihypertensive medication in women
González‐Pérez, A., Ronquist, G., & Rodríguez, L. A. G. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.910 · Cited by 39
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill
Black, C., Kaye, J. A., & Jick, H. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01606.x · Cited by 23
Cited by
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yang, Y.-X., Lewis, J. D., Epstein, S., & Metz, D. C. (2006) · JAMA · doi:10.1001/jama.296.24.2947 · Cited by 1,214
Self-citationCollaborative, T. O., Williamson, E., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., et al. (2020) · doi:10.1101/2020.05.06.20092999 · Cited by 6,674
“19 Patients were observed from the 1st of February 2020 and were followed until the first of either their death date (whether COVID-19 related or due to other causes) or the study end date, 25th April 2020.”
BackgroundPrediagnostic presentations of Parkinson’s disease in primary care: A case-control study
Schrag, A., Horsfall, L., Walters, K., Noyce, A., & Petersen, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70287-x · Cited by 674
OLIVIER, C., ROBERT, P. D., DAIHUNG, D., URBÀ, G., CATALIN, M. P., HYWEL, W., Kurd, S. K., Troxel, A. B., Crits-Christoph, P., & Gelfand, J. M. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.186 · Cited by 642
Metadata
- Authors
- Lewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 14
- Issue
- 7
- Pages
- 443-451
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2069381373
- Cited by
- 341
- References
- 34
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.